Source: FierceBiotech In victory for industry, FDA's second attempt to classify Prevor's skin wash as a device is vacated once again. The U.S. District Court for the District of Columbia rejected the FDA's attempt to classify Prevor's Diphoterine Skin Wash as a drug rather than a device for the second…...
AbbVie partners with Google’s Calico on $1.5B R&D operation focused on aging
Source: FierceBiotech Hot on the heels of its $805 million development deal with Infinity, AbbVie Pharmaceuticals ($ABBV) has followed up today with a plan to partner with Google's ($GOOG) closely watched biotech upstart Calico on a new research operation that will cost up to $1.5 billion to get started. Google-backed…...